McNeish IA - Search Results

1

RAD51 and BRCA2 Enhance Oncolytic Adenovirus Type 5 Activity in Ovarian Cancer.

Tookman LA, Browne AK, Connell CM, Bridge G, Ingemarsdotter CK, Dowson S, Shibata A, Lockley M, Martin SA, McNeish IA. Tookman LA, et al. Among authors: mcneish ia. Mol Cancer Res. 2016 Jan;14(1):44-55. doi: 10.1158/1541-7786.MCR-15-0188-T. Epub 2015 Oct 9. Mol Cancer Res. 2016. PMID: 26452665 Free PMC article.

2

Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis.

McNeish IA, Lopes R, Bell SJ, McKay TR, Fernandez M, Lockley M, Wheatley SP, Lemoine NR. McNeish IA, et al. Exp Cell Res. 2005 Jan 1;302(1):69-82. doi: 10.1016/j.yexcr.2004.08.029. Exp Cell Res. 2005. PMID: 15541727

3

Activity of the adenoviral E1A deletion mutant dl922-947 in ovarian cancer: comparison with E1A wild-type viruses, bioluminescence monitoring, and intraperitoneal delivery in icodextrin.

Lockley M, Fernandez M, Wang Y, Li NF, Conroy S, Lemoine N, McNeish I. Lockley M, et al. Cancer Res. 2006 Jan 15;66(2):989-98. doi: 10.1158/0008-5472.CAN-05-2691. Cancer Res. 2006. PMID: 16424034

4

Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography imaging.

Leyton J, Lockley M, Aerts JL, Baird SK, Aboagye EO, Lemoine NR, McNeish IA. Leyton J, et al. Among authors: mcneish ia. Cancer Res. 2006 Sep 15;66(18):9178-85. doi: 10.1158/0008-5472.CAN-06-1539. Cancer Res. 2006. PMID: 16982761

5

Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer.

Baird SK, Aerts JL, Eddaoudi A, Lockley M, Lemoine NR, McNeish IA. Baird SK, et al. Among authors: mcneish ia. Oncogene. 2008 May 15;27(22):3081-90. doi: 10.1038/sj.onc.1210977. Epub 2007 Dec 10. Oncogene. 2008. PMID: 18071311 Free PMC article.

6

Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis.

Connell CM, Wheatley SP, McNeish IA. Connell CM, et al. Among authors: mcneish ia. Cancer Res. 2008 Oct 1;68(19):7923-31. doi: 10.1158/0008-5472.CAN-08-0817. Cancer Res. 2008. PMID: 18829549

7

In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery.

Coughlan L, Vallath S, Saha A, Flak M, McNeish IA, Vassaux G, Marshall JF, Hart IR, Thomas GJ. Coughlan L, et al. Among authors: mcneish ia. J Virol. 2009 Jul;83(13):6416-28. doi: 10.1128/JVI.00445-09. Epub 2009 Apr 15. J Virol. 2009. PMID: 19369326 Free PMC article.

8

Oncolytic adenoviral gene therapy in ovarian cancer: why we are not wasting our time.

Young A, McNeish IA. Young A, et al. Among authors: mcneish ia. Future Oncol. 2009 Apr;5(3):339-57. doi: 10.2217/fon.09.11. Future Oncol. 2009. PMID: 19374541 Review.

9

Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours.

Merron A, Baril P, Martin-Duque P, de la Vieja A, Tran L, Briat A, Harrington KJ, McNeish IA, Vassaux G. Merron A, et al. Among authors: mcneish ia. Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1377-85. doi: 10.1007/s00259-009-1379-3. Epub 2010 Feb 6. Eur J Nucl Med Mol Imaging. 2010. PMID: 20140612

10

CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus.

Elmetwali T, Searle PF, McNeish I, Young LS, Palmer DH. Elmetwali T, et al. Mol Cancer. 2010 Mar 8;9:52. doi: 10.1186/1476-4598-9-52. Mol Cancer. 2010. PMID: 20211016 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters